Tag Archives: PTLA

Top 5 Heal Care Stocks For 2019

China’s first big jetliner just passed a crucial test that will take the country a step closer to becoming one of the world’s elite large airline makers.

The C919 airliner, which is produced by the Commercial Aircraft Corporation of China, or Comac, finished its final ground trial on Sunday in Shanghai.

Test pilots sped the C919 down the runway at Pudong International Airport, lifting the nose of the jet into the air and slamming on the brakes.

Before the airplane could make its maiden flight — expected before the end of May — the pilots had to demonstrate the jet can safely stop on the runway in case something goes wrong.

The 168-seat C919 is roughly the same size as Airbus’s A320 and Boeing’s 737-800, which are the most popular airliners in the world.

From the outside, China’s new airliner looks familiar. Its design is a hybrid of western aerospace companies and Chinese industry, and its engines are nearly identical to those on the newest Airbus models.

Top 5 Heal Care Stocks For 2019: Duke Energy Corporation(DUK)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    When it comes to investing, including some boring, defensive stocks in your portfolio is a good thing. This is because investors often forget that markets go both up and down. The market is in a positive mood lately, which is exactly why you will want to consider this trio of boring utility stocks. Here’s why American Water Works, Inc. (NYSE:AWK), Duke Energy Corporation (NYSE:DUK), and Dominion Energy, Inc. (NYSE:D) are all defensive stocks you might want to consider adding to your portfolio today.

  • [By Chris Lange]

    Duke Energy Corp. (NYSE: DUK) shares were up 2.6% at $76.24. The stock has a 52-week range of $72.93 to $91.80 and a consensus price target of $86.13.

  • [By ]

    1. Duke Energy (NYSE: DUK)
    Defensive utility stocks that pay a steady dividend are one way to start building your bear market moat. No matter how bad things may get, utilities are a must for our modern life.

  • [By Max Byerly]

    State of Tennessee Treasury Department trimmed its holdings in shares of Duke Energy Corp (NYSE:DUK) by 31.5% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 168,107 shares of the utilities provider’s stock after selling 77,341 shares during the period. State of Tennessee Treasury Department’s holdings in Duke Energy were worth $13,023,000 at the end of the most recent reporting period.

Top 5 Heal Care Stocks For 2019: Portola Pharmaceuticals, Inc.(PTLA)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media stories about Portola Pharmaceuticals (NASDAQ:PTLA) have been trending somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Portola Pharmaceuticals earned a news impact score of 0.13 on Accern’s scale. Accern also assigned media headlines about the biopharmaceutical company an impact score of 46.8096111737325 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Todd Campbell]

    You can’t turn back the clock and buy Celgene12 years ago when it first won approval for its multibillion-dollar blockbuster multiple myeloma drug Revlimid, but you can buy stocks that have similar prospects. One such company is Portola Pharmaceuticals (NASDAQ:PTLA), an emerging commercial-stage biotech that’s recently won Food and Drug Administration (FDA) approval for two potential blockbuster drugs.

  • [By Lisa Levin] Gainers
    Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares jumped 29.86 percent to close at $2.87 on Friday.
    Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares gained 28.87 percent to close at $8.75 after reporting upbeat Q1 earnings.
    Mexco Energy Corporation (NYSE: MXC) gained 27.02 percent to close at $5.4744.
    Carbon Black, Inc. (NASDAQ: CBLK) climbed 26 percent to close at $23.94. Carbon Black priced its IPO at $19 per share.
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 25.64 percent to close at $42.44 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.
    Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.19 percent to close at $8.50 after reporting Q2 results.
    California Resources Corporation (NYSE: CRC) shares gained 22.45 percent to close at $31.58 following upbeat Q1 earnings.
    Atomera Incorporated (NASDAQ: ATOM) gained 22.31 percent to close at $6.25 after reporting Q1 results.
    Medifast, Inc. (NYSE: MED) shares jumped 22.27 percent to close at $121.46 after the company reported strong Q1 results and raised its FY18 guidance.
    Jerash Holdings (US), Inc. (NASDAQ: JRSH) gained 20.86 percent to close at $8.46.
    Pandora Media, Inc. (NYSE: P) rose 19.83 percent to close at $6.89 after reporting strong quarterly results.
    Shake Shack Inc (NYSE: SHAK) rose 18.01 percent to close at $55.95 on Friday after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Super Micro Computer, Inc. (NASDAQ: SMCI) rose 17.73 percent to close at $21.25 after reporting strong preliminary results for the third quarter.
    Schmitt Industries, Inc. (NASDAQ: SMIT) rose 17.41 percent to close at $2.36.
    Titan International, Inc. (NYSE: TWI) shares gained 16.78 percent to close at $12.25 following Q1 earnings.
    Integer Holdings Corporation (NYSE: ITGR) shares rose 14.23 percent to close at $63.40 following Q1 result
  • [By ]

    Portola Pharmaceuticals (PTLA) : “The news is already in this story. I’d rather be in something better.”

    STMicroelectronics (STM) : “No. You want Cisco Systems (CSCO) ahead of when they report.”

Top 5 Heal Care Stocks For 2019: CVS Health Corporation(CVS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Tokio Marine Asset Management Co. Ltd. lessened its stake in CVS Health (NYSE:CVS) by 38.6% in the first quarter, HoldingsChannel reports. The firm owned 3,614 shares of the pharmacy operator’s stock after selling 2,274 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in CVS Health were worth $225,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CVS Health (CVS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    CVS Health Corp (NYSE: CVS)
    What does the integrated healthcare company of the future look like? CVS. With its already vast pharmacy and pharmacy benefit management footprint, the company is upping its game by acquiring healthcare insurer Aetna (NYSE: AET).

Top 5 Heal Care Stocks For 2019: Alcatel Lucent(ALU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media coverage about Alcatel Lucent (NYSE:ALU) has been trending somewhat positive this week, Accern reports. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Alcatel Lucent earned a media sentiment score of 0.08 on Accern’s scale. Accern also gave headlines about the communications equipment provider an impact score of 45.9413628150958 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 5 Heal Care Stocks For 2019: Omnicom Group Inc.(OMC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Omicron (CURRENCY:OMC) traded flat against the dollar during the 1 day period ending at 18:00 PM ET on May 21st. One Omicron coin can currently be purchased for $0.13 or 0.00001569 BTC on major exchanges. Over the last week, Omicron has traded 2.8% lower against the dollar. Omicron has a market capitalization of $0.00 and approximately $0.00 worth of Omicron was traded on exchanges in the last 24 hours.

  • [By Logan Wallace]

    Omnicom Group (NYSE: OMC) and Publicis Groupe (OTCMKTS:PUBGY) are both large-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

  • [By Ethan Ryder]

    New York State Common Retirement Fund cut its stake in Omnicom Group Inc. (NYSE:OMC) by 1.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 566,726 shares of the business services provider’s stock after selling 7,045 shares during the quarter. New York State Common Retirement Fund owned approximately 0.25% of Omnicom Group worth $41,184,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Joseph Griffin]

    Highbridge Capital Management LLC increased its position in shares of Omnicom Group Inc. (NYSE:OMC) by 3,014.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 14,571 shares of the business services provider’s stock after buying an additional 15,071 shares during the quarter. Highbridge Capital Management LLC’s holdings in Omnicom Group were worth $1,059,000 as of its most recent SEC filing.

Top 5 China Stocks To Watch Right Now

Billionaire Jack Ma, chairman of Alibaba Group Holding Ltd., speaks during a session at the China Green Companies Summit in Zhengzhou, China, on Sunday, April 23, 2017. Ma said society should prepare for decades of pain as the internet disrupts the economy. Photographer: Qilai Shen/Bloomberg

Alibaba Inc. is scheduled to release earnings before Thursday’s open. The stock just hit a record high of $124.34/share on Tuesday and is currently trading near $124/share. The stock is prone to big moves after reporting earnings and can easily gap up if the numbers are strong. Conversely, if the numbers disappoint, the stock can easily gap down. To help you prepare, here is what the Street is expecting:

Earnings Preview: Jan-March 2017

Alibaba Inc. is expected to report $0.66/share on $5.20 billion in revenue. Meanwhile, the so-called Whisper number is $0.76. The Whisper number is the Street’s unofficial view on earnings.

Top 5 China Stocks To Watch Right Now: Tenneco Inc.(TEN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Tokenomy (CURRENCY:TEN) traded 0.7% lower against the dollar during the one day period ending at 23:00 PM ET on May 13th. In the last seven days, Tokenomy has traded down 18.2% against the dollar. One Tokenomy token can now be purchased for approximately $0.26 or 0.00003099 BTC on major cryptocurrency exchanges. Tokenomy has a market capitalization of $32.49 million and approximately $411,692.00 worth of Tokenomy was traded on exchanges in the last day.

  • [By Logan Wallace]

    Gentex (NASDAQ: GNTX) and Tenneco (NYSE:TEN) are both mid-cap auto/tires/trucks companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends.

  • [By Jim Crumly]

    As for individual stocks,Verifone Systems (NYSE:PAY) is being acquired by a group of private investors, and Tenneco (NYSE:TEN) is buying an auto parts business before splitting into two public companies.

  • [By Joseph Griffin]

    Tenneco (NYSE: TEN) and China Automotive Systems (NASDAQ:CAAS) are both auto/tires/trucks companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends and valuation.

Top 5 China Stocks To Watch Right Now: Provident Financial Services, Inc(PFS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

    Get Provident Financial Services alerts:

    Head-To-Head Review: Provident Financial (PROV) versus Provident Financial Services (PFS) (americanbankingnews.com) Head-To-Head Contrast: Territorial Bancorp (TBNK) & Provident Financial Services (PFS) (americanbankingnews.com) Q3 2018 EPS Estimates for Provident Financial Services, Inc. Decreased by Piper Jaffray (PFS) (americanbankingnews.com) Provident Financial Services, Inc. (PFS) Given Average Rating of “Hold” by Brokerages (americanbankingnews.com)

    A number of research analysts have issued reports on PFS shares. Sandler O’Neill raised shares of Provident Financial Services from a “hold” rating to a “buy” rating and set a $29.00 price objective on the stock in a research report on Friday, January 26th. ValuEngine raised shares of Provident Financial Services from a “hold” rating to a “buy” rating in a research report on Wednesday, March 7th. Zacks Investment Research downgraded shares of Provident Financial Services from a “buy” rating to a “hold” rating in a research report on Wednesday, February 21st. Boenning Scattergood reissued a “hold” rating on shares of Provident Financial Services in a research report on Monday, January 29th. Finally, Piper Jaffray reissued a “hold” rating and set a $28.00 price objective on shares of Provident Financial Services in a research report on Tuesday, January 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. Provident Financial Services currently has a consensus rating of “Hold” and an average price target of $28.42.

Top 5 China Stocks To Watch Right Now: Portola Pharmaceuticals, Inc.(PTLA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Portola Pharmaceuticals (NASDAQ:PTLA) has been given a $80.00 target price by equities research analysts at Oppenheimer in a research note issued to investors on Sunday. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. Oppenheimer’s price target points to a potential upside of 88.50% from the stock’s previous close.

  • [By Keith Speights]

    Three big healthcare winners this week were STAAR Surgical (NASDAQ:STAA), Tenet Healthcare (NYSE:THC), and Portola Pharmaceuticals (NASDAQ:PTLA). Each of these stocks jumped more than 24% over the last few days. Are STAAR Surgical, Tenet, and Portola smart picks for investors after the stocks’ huge gains?

  • [By Lisa Levin]

    Shares of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) got a boost, shooting up 25 percent to $42.23 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.

  • [By Todd Campbell]

    In this episode of The Motley Fool’s Industry Focus: Healthcare, analysts Kristine Harjes and Todd Campbell discuss if the criticism is fair and if athenahealth’s likely to be acquired. Also, they update investors onTakeda’s plan to merge withShire Plc(NASDAQ:SHPG) in a $62 billion deal and howpatience finally paid off forPortola Pharmaceuticals(NASDAQ:PTLA) investors.

Top 5 China Stocks To Watch Right Now: Nielsen N.V.(NLSN)

Advisors’ Opinion:

  • [By Keith Noonan, Rich Smith, and Timothy Green]

    With that in mind, we asked three Motley Fool investors to profile an income-generating stock that’s currently flying under the radar but has some truly amazing qualities. Read on to see why they thinkNielsen Holdings (NYSE:NLSN), Vail Resorts (NYSE:MTN), and The Walt Disney Company (NYSE:DIS)are top dividend stocks that aren’t getting their due.

  • [By John Ballard]

    But in order to attract advertisers — which along with sponsorships is expected to make up 77% of the esports market this year — there has to be verifiable data about who is watching and for how long. NielsenHoldings’ (NYSE:NLSN) TV ratings are the “currency” of media buyers. Last year, Nielsen announced a new ratings service specifically for esports and has now partnered with Activision to provide verifiable ratings for its top esports ventures, including Overwatch League and Call of Duty World League.

  • [By Joseph Griffin]

    These are some of the news articles that may have effected Accern’s scoring:

    Get GGP alerts:

    Read This Before Trade: Facebook, Inc. (FB), GGP Inc. (GGP) (nmsunews.com) Ggp Inc (GGP)’s Weekly Performance of -0.90% Is Nothing to Write Home About (parkcitycaller.com) Is GGP Inc (NYSE:GGP) A Good Dividend Stock? (finance.yahoo.com) GGP (GGP) Downgraded by Zacks Investment Research to “Hold” (americanbankingnews.com) Dazzling Stocks: GGP Inc. (NYSE:GGP), Nielsen Holdings plc (NYSE:NLSN), AmerisourceBergen Corporation (NYSE … (thestreetpoint.com)

    GGP has been the subject of a number of recent research reports. Royal Bank of Canada restated a “buy” rating and set a $24.00 target price on shares of GGP in a research report on Monday, February 12th. Boenning Scattergood reissued a “buy” rating and issued a $35.00 target price on shares of GGP in a research note on Tuesday, March 27th. Mizuho raised GGP from a “neutral” rating to a “buy” rating and set a $24.00 target price for the company in a research note on Monday, March 19th. Zacks Investment Research upgraded GGP from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a report on Wednesday, April 11th. Finally, Barclays cut their price target on GGP from $24.00 to $23.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 30th. Three analysts have rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company’s stock. GGP currently has an average rating of “Hold” and a consensus price target of $24.92.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was Nielsen Holdings PLC (NYSE: NLSN) which traded down over 9% at $33.99. The stocks 52-week range is $33.90 to $45.73. Volume was 11.3 million compared to the daily average volume of 3.8 million.

  • [By Joseph Griffin]

    ARP Americas LP grew its position in Nielsen Holdings (NYSE:NLSN) by 41.2% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 14,400 shares of the business services provider’s stock after buying an additional 4,200 shares during the period. ARP Americas LP’s holdings in Nielsen were worth $458,000 as of its most recent SEC filing.

Top 5 China Stocks To Watch Right Now: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Investors bought shares of Exelon (NYSE:EXC) on weakness during trading on Wednesday. $34.07 million flowed into the stock on the tick-up and $18.56 million flowed out of the stock on the tick-down, for a money net flow of $15.51 million into the stock. Of all stocks tracked, Exelon had the 24th highest net in-flow for the day. Exelon traded down ($0.42) for the day and closed at $39.79

Top Insurance Stocks To Invest In 2018

Who Should Pay More for Insurance: Smokers or Significantly Overweight?

Trump Efforts to Kill ACA Elicit Court Actions, Investigations

25 Best Countries for Retirement Security: 2017

Employers are looking to their health insurance brokers to keep health care costs under control as the health care landscape is beset by turmoil. 

That’s according to a report from DirectPath, in which 83 percent of brokers report that employers are expecting them to assist in keeping down what they spend on health care. Brokers, for their part, are responding with a range of new products and services. In fact, 78 percent of brokers have introduced something new in the past year to help their employer customers control health care costs.

Originally published on BenefitsPro. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. padding: 0px 81px;width: inherit; Retirement Wire

Your resource for news, research and analysis to help you deliver more effective outcomes to your clients. Resources [Advisor Tool] Survivor Income and Cash Needs Analysis Worksheet

Help your clients secure their loved ones’ future with this useful worksheet.

Top Insurance Stocks To Invest In 2018: Portola Pharmaceuticals, Inc.(PTLA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 23 percent to $21.92 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 16 percent to $20.43. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 30 percent to $20.08 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 14 percent to $20.96. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

  • [By Todd Campbell]

    Portola Pharmaceuticals’ (NASDAQ:PTLA)could have two commercial-stage drugs on the market next year, but turning them into top-sellers will require a lot of money. Is Portola Pharmaceuticals’ balance sheet flush enough with cash to get its drugs across the finish line?

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares were also up, gaining 46 percent to $55.68 after the company disclosed that the FDA has approved Bevyxxa, a blood-thinner for acutely ill patients not undergoing surgery. BevyxXa is the first oral drug of its kind to be approved to help prevent deep vein thrombosis and pulmonary embolisms..

Top Insurance Stocks To Invest In 2018: TripAdvisor, Inc.(TRIP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Avon Products, Inc. (NYSE: AVP) to report quarterly earnings at $0.10 per share on revenue of $1.62 billion before the opening bell. Avon Products shares rose 2.39 percent to $6.00 in after-hours trading.
    Analysts expect MGM Resorts International (NYSE: MGM) to report quarterly earnings at $0.20 per share on revenue of $2.44 billion before the opening bell. MGM shares rose 1.01 percent to $29.90 in after-hours trading.
    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected results for its second quarter and raised its quarterly dividend to $0.29 per share. Cisco shares rose 2.13 percent to $33.52 in the after-hours trading session.
    Before the markets open, Dean Foods Co (NYSE: DF) is projected to report its quarterly earnings at $0.41 per share on revenue of $2.01 billion. Dean Foods shares rose 0.49 percent to $20.55 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) posted weaker-than-expected results for its fourth quarter on Wednesday. Tripadvisor shares dropped 5.60 percent to $49.75 in the after-hours trading session.
    Analysts are expecting Waste Management, Inc. (NYSE: WM) to have earned $0.77 per share on revenue of $3.42 billion in the latest quarter. Waste Management will release earnings before the markets open. Waste Management shares rose 2.27 percent to $72.97 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Ben Levisohn]

    TripAdvisor (TRIP) tumbled to the bottom of the S&P 500 today after reporting earnings that came in well below the Street consensus.

    Agence France-Presse/Getty Images

    TripAdvisordropped 11% to $46.92 today, while the S&P 500 dipped 0.1% to2,347.22.

    Susquehanna’s Shyam Patil and team write that TripAdvisor’s “challenges persist.” They explain why:

    4Q highlights another challenging quarter. Total revenue was $316m (up 2% y/y), 1% below our estimate of $320m and 3% below consensus of $327m. EBITDA of $58m (18.4% margins) was ~25% below our and the consensus estimate of $77m, caused by the revenue miss and higher opex (specifically S&M and G&A) vs. our model…

    While we like TRIPs leading audience reach (on both mobile and desktop) and breadth of travel content, we believe the traffic mix shift to mobile combined with the transition to instant book (IB) will continue to weigh on monetization and cause near-term volatility in the numbers. TRIP is prioritizing revenue growth over profits this year, and management expects to drive double-digit revenue growth but at the expense of significant margin deleverage and absolute EBITDA declines. Additionally, EBITDA could decline further, if TRIP decides to do TV advertising, which is currently not in our estimates or managements outlook. Given these issues, forecasting remains challenging and we continue to have little confidence in estimates.

    TripAdvisor’s market capitalization fell to $6.8 billion today from $7.6 billion yesterday.

  • [By Ben Levisohn]

    TripAdvisor (TRIP) tumbled to the bottom of the S&P 500 today, a reversal of yesterday’s big gain following the news thatExpedia (EXPE) would participate in its Instant Booking program.

    Agence France-Presse/Getty Images

    TripAdvisordropped 5.1% to $46.28 today, while the S&P 500 declined 0.3% to 2,265.18.

    In a note published yesterday, SunTrust Robinson Humphrey’s Rodney Hull and team called the announcement a “positive for [the] platform” but worried about the fact that “shopper growth and monetization have been muted.” They explain:

    Ultimately, TripAdvisor is seeking to improve its revenue per shopper which trails its OTA peers who earn 4-5x more per shopper by driving booking and repeat booking activity on their sites. On a positive note, TripAdvisor stated that US trends improved through the third quarter and that transaction revenue and rev/shopper turned positive in October. Further, green shoots in app bookings and vaulted credit cards are noteworthy. However, the dual headwinds of mobile and the IB transition continue to negatively impact financials as well as the “flywheel” for shopper growth and visibility into improving growth remains limited, aside from easing comps. We have a positive view of the company’s longer-term monetization opportunity, but we await further signs of inflection in growth and profitability, which may follow a larger ad campaign. Recall, the company reduced its margin outlook for 2017 on the 3Q call as it will likely look to increase paid marketing spend and invest revenue per shopper gains to restart the flywheel

    TripAdvisor’s market capitalization fell to $6.7 billion today from $7.1 billion yesterday. It reported net income of $198 million on sales of $1.5 billion in 2015.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was TripAdvisory, Inc. (NASDAQ: TRIP) which traded down about 23% at $30.35. The stocks 52-week range is $30.21 to $65.56. Volume was roughly29 million versus the daily average 3.1 million shares.

Top Insurance Stocks To Invest In 2018: Oil States International Inc.(OIS)

Advisors’ Opinion:

  • [By Wayne Duggan]

    Instead, Genargo prefers oil services stocks with the most exposure to the U.S market. Loop names Halliburton Company (NYSE: HAL) as its top large-cap stock pick and Oil States International, Inc. (NYSE: OIS), Newpark Resources Inc (NYSE: NR) and Superior Energy Services, Inc. (NYSE: SPN) as its top small- and mid-cap stocks.

  • [By Michael J. Carr]

    Einhorn selects investments with a traditional value approach, although he may not be as patient as a typical value investor. Einhorn took Apple (Nasdaq: AAPL) to court in an effort to force the company to return cash to shareholders, and more recently challenged Oil States International (NYSE: OIS) to unlock shareholder value.

wall street stock market

Tesla’s stock was up $20 to an all-time high of $298.52 on Monday which gave the company a market cap of $48.7 billion and the shares are up another $5 today to break $300. This pushed Tesla’s market cap higher than Ford’s $45.5 billion and is closing in on GM’s $51.2 billion.

There were what I’d call two and a half reasons for Tesla’s stock price to pop on Monday. The top two were a short squeeze and a bullish note from Morgan Stanley and the half reason was the company reporting its March quarter deliveries and production which were a bit better than expected.

Tesla Motors unveils the new lower-priced Model 3 sedan at the Tesla Motors design studio in Hawthorne, Calif. (AP Photo/Justin Pritchard)

Shorts are taking it in the shorts

wall street stock market: Maxwell Technologies, Inc.(MXWL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Maxwell Technologies Inc. (NASDAQ: MXWL) were down 15 percent to $5.34. Maxwell reported amended terms for deal with Viex Capital and announced a proposed offering of $50 million convertible senior notes due 2022.

  • [By Monica Gerson]

    Maxwell Technologies (NASDAQ: MXWL) surged 9.20% to $10.21. The volume of Maxwell Technologies shares traded was 325% higher than normal. Maxwell’s trailing-twelve-month revenue is $190.57 million.

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedgoing long on small cap energy storage and power delivery stock Maxwell Technologies (NASDAQ: MXWL):

wall street stock market: Portola Pharmaceuticals, Inc.(PTLA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 23 percent to $21.92 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 16 percent to $20.43. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

  • [By Lisa Levin]

    Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares dropped 30 percent to $20.08 after announcing Phase III Betrixaban results.

    Shares of Spark Energy Inc (NASDAQ: SPKE) were down 14 percent to $20.96. Spark Energy reported Q4 GAAP EPS of $(0.01) and adjusted EBITDA of $16.3 million.

  • [By Todd Campbell]

    Portola Pharmaceuticals’ (NASDAQ:PTLA)could have two commercial-stage drugs on the market next year, but turning them into top-sellers will require a lot of money. Is Portola Pharmaceuticals’ balance sheet flush enough with cash to get its drugs across the finish line?

wall street stock market: Sagent Pharmaceuticals Inc.(SGNT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Sagent Pharmaceuticals Inc (NASDAQ: SGNT) got a boost, shooting up 40 percent to $21.65 as the company agreed to be acquired by Nichi-Iko Pharmaceutical for $21.75 per share. RBC Capital downgraded Sagent Pharmaceuticals from Outperform to Sector Perform.

wall street stock market: Envision Healthcare Holdings, Inc.(EVHC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Envision Healthcare Holdings Inc (NYSE: EVHC) shares shot up 211 percent to $70.15. Envision Healthcare and Amsurg Corp (NASDAQ: AMSG) reported the completion of their merger.

  • [By Paul Ausick]

    Envision Healthcare Corp. (NYSE: EVHC) dropped about 9.3% Tuesday to post a new 52-week low of $43.22 after closing Monday at $47.67. The 52-week high is $74.75. Volume of around 10 million shares traded was about six times the daily average. The company had no specific news.

  • [By Ben Levisohn]

    Even on a day like today, somebody had to be the worst performer in the S&P 500, and today that somebody is Envision Healthcare (EVHC), which missed earnings forecasts last night.

wall street stock market: Constellation Brands Inc(STZ)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Constellation Brands (STZ) has rallied 4.7% to $169 after beating earnings forecasts and offering optimistic guidance.

    Greenbrier Cos. (GBX) has advanced 2.1% to $48.25 after getting upgraded to Buy from Neutral at BofA Merrill Lynch.

  • [By WWW.THESTREET.COM]

    Then on Thursday, Constellation Brands (STZ) reports, and as we learned yesterday, this is Cramer’s favorite liquor stock. Also on Thursday, earnings from Nike (NKE) , a battleground Cramer said he’s steering clear of, and Micron Technology (MU) , which will likely fall no matter how good its quarter.

  • [By Rich Duprey]

    It’s not all bad news, as brewers such as Lagunitas and Dogfish Head, among others, were up by double-digit percentages. Constellation Brands (NYSE:STZ) also surged, and though much of that increase might be attributable to its imported Corona brands, it also has its Ballast Point craft brand to thank, as it’s been living up to its reputation as the fastest-growing craft beer.

  • [By ]

    Earlier this quarter, I told you how alcohol distributor Constellation Brands Inc. (NYSE:STZ) acquired a 10% stake in Canadian medical marijuana firm Canopy Growth Corp. (TSE:WEED). A major alcohol distributor buying a marijuana company would have been unfathomable just a few years ago. But with legalization gaining steam nationwide, this deal is shaping up to be one of many to come in the industry.

  • [By WWW.THESTREET.COM]

    Is it time to crown a new king of beers? After speaking with Constellation Brands (STZ) CEO on Thursday night’s show, Cramer said it was time to take a fresh look at the beer sector to see if a reshuffling is in order.

  • [By Craig Jones]

    Najarian also noticed big upside call options buying in Constellation Brands, Inc. (NYSE: STZ). Around 5,000 contracts of the January 240 calls were traded and he decided to follow the trade. He added that he also likes Wal-Mart Stores Inc (NYSE: WMT) for upside calls buying.

wall street stock market: Cott Corporation(COT)

Advisors’ Opinion:

  • [By Dan Moskowitz]

    Cott (NYSE: COT  ) produces and sells over 200 different types of beverages in over 50 countries, and it implements a highly effective strategy. Cott is what is known as a Fast Follower, which makes it unique to other beverage companies.

Portola Pharmaceuticals: What The Early FDA Approval Of Bevyxxa PAS Entails

On Dec. 20, 2017, the shares of Portola Pharmaceuticals (NASDAQ:PTLA), a bioscience specializing in the innovation and commercialization of drugs to treat blood disorders and cancers increased $4.13 to $55.12 (8.09% profits for traders) as of 2:01 pm EST. Previously, in part I and II research on the said firm, we went into details about the anticancer molecule cerdulatinib, and the Juggernaut Capital shareholders activism, respectively. In part III, we talked about the prospects of AndexXa (the FDA designated breakthrough therapy). Much substantial values to be unlocked in Bevyxxa was discussed in part IV. Today, more good news came in, as the FDA approved the Prior Approval Supplement (PAS) for Bevyxxa ahead of schedule.

Figure 1: ABC stock chart. (Source: Stockcharts).

At Integrated BioSci Investing, we have much success in finding robust performers. For instance, Nektar Therapeutics (NASDAQ:NKTR) appreciated over 210% for subscribers. In this report, we’ll elucidate the PAS approval and to assess its prospects as a potential big winner for you.

Fundamentals Analysis

Based in South San Francisco, Portola is specializing in the innovation and commercialization of therapeutics to manage blood disorders and cancers. Of the three products – betrixaban (Bevyxxa), andexanet alfa (AndexXa), and cerdulatinib – in the drug portfolio, Bevyxxa was FDA approved as the long-term prophylaxis for blood clots or venous thromboembolism (VTE) in adult patients on June 23, 2017. AndexXa, as a potential antidote for life-threatening bleeds (associated with Factor Xa inhibitors), is awaiting regulatory decisions (FDA by Feb. 2 and CHMP in Q1 next year).

Figure 2: Therapeutic pipeline. (Source: Portola).

As mentioned, Bevyxxa received the FDAs nod earlier in the year (as a monotherapy in the hospital and post-discharge to prevent blood clots in at risks adults for up to 35-42 days. These patients are hospitalized due to an acute medical illness (and are at risks due to VTE-related risks factors as well as moderate to severely restricted mobility).

With the early PAS approval, Portola can now initiate the commercialization of Bevyxxa as soon as beginning in Jan. 2018. Further launch-update will be provided during the next investor presentation (anticipated on Jan. 09). According to CEO Bill Lis,

We are pleased to be able to make Bevyxxa available to acute medically ill patients at high risk of venous thromboembolism beginning in January 2018. VTEs result in approximately 100,000 deaths annually in the U.S. in acute medically ill patients and they are preventable. As the first and only anticoagulant approved as a single-drug regimen administered in the hospital and (following) discharge for a treatment duration of 35-42 days, Bevyxxa has the potential to impact public health in the US and beyond, if approved in other countries. We thank the FDA for its guidance throughout the review process and look forward to continuing our collaborative efforts with the agency for the benefit of patients.

In all, the main risk for Bevyxxa at this point is that the molecule might not generate significant sales to justify the invested capital for its innovation and launch. Despite its $3.57B market capitalization, Portola is still relatively small in size (and does not arguably have the robust resources like large pharmaceutical firms to execute an aggressive launch). Hence, there can be a potentially slow rollout. Nevertheless, our analysis revealed that launch will pick up pace due to the stellar profiles of the said molecule to deliver a potential blockbuster. And, the aforesaid early PAS approval should assuage at least some investor concerns regarding the managements competence. Last but not least, there is an in-depth Integrated BioSci research (published in advanced to subscribers), which featured other powerful catalysts brewing in this company.

Author Note: We’re honored that you took the time out of your busy day to read our market intelligence. Founded by Dr. Hung Tran, MD, MS, CNPR, (in collaborations with Dr. Tran BioSci analyst, Ngoc Vu, and other PhDs), Integrated BioSci Investing marketplace research is delivering stellar returns since inceptions. To name a few, Nektar Therapeutics procured more than 190% profits while Spectrum Pharmaceuticals (SPPI) delivered over 180% gains. Our secret sauce is extreme due diligence coupled with expert data analysis. The service features a once-weekly exclusive in-depth Integrated BioSci article (in the form of research, reports, or interviews), daily individual stocks consulting, and model portfolios.

Notably, we’ll increase prices soon. Subscribe to our Marketplace research now to lock in the legacy price and save money in the future.To receive real-time alerts on our articles as well as blogs, be sure to check out our profile page and click on the orange Follow button. Besides the exclusives, this article is the truncated version of the research we published in advance to IBI subscribers. Further, you can read up on Dr. Trans background by following this link.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

About this article:ExpandAuthor payment: $35 + $0.01/page view. Authors of PRO articles receive a minimum guaranteed payment of $150-500.Tagged: Investing Ideas, Quick Picks & Lists, Healthcare, Drug Related ProductsWant to share your opinion on this article? Add a comment.Disagree with this article? Submit your own.To report a factual error in this article, click here